Patanjali Responds to Maharashtra FDA Action, Says No Lab Report Confirms Cow Ghee Quality Failure

Patanjali Foods has clarified that no authenticated laboratory report has established a quality failure in certain batches of its cow ghee following action by Maharashtra’s Food and Drug Administration (FDA). The company said the regulatory communication concerned stock held by one of its super distributors in Maharashtra and was not issued directly to Patanjali Foods.

The clarification follows a festive-season enforcement drive during which Maharashtra FDA seized more than 2,200 litres of Patanjali Cow Ghee from a distributor in Chhatrapati Sambhajinagar. The regulator restricted the sale of the identified stock pending further action. Patanjali Foods said samples had been collected for testing but maintained that the seizure and sampling process alone did not establish adulteration or non-compliance with food safety standards.

Maharashtra FDA Seizes 2,279 Litres of Patanjali Cow Ghee

The Maharashtra FDA conducted a special enforcement drive targeting food safety violations during the festive season.

During the operation, officials took action against M/s Divya Mahavitarak, a super distributor of Patanjali Ayurved located in Sundarwadi, Chhatrapati Sambhajinagar.

According to reports, the regulator seized 4,032 units of Patanjali Cow Ghee, equivalent to approximately 2,279 litres, across two batches. The seized stock was valued at around ₹20 lakh.

The FDA initiated the action under Section 38(1)(c) of the Food Safety and Standards Act, 2006, citing suspicion of misbranding or adulteration. The department said the products were prima facie found to be in contravention of the Act.

The action included restrictions concerning the identified stock, preventing its sale pending further regulatory proceedings.

Importantly, the seizure was based on the regulator’s initial action and did not, by itself, establish a confirmed laboratory finding of adulteration.

Patanjali Says FDA Notice Was Issued to Distributor

In a regulatory filing dated November 3, 2026, Patanjali Foods clarified that the communication concerning the seized stock was issued to the concerned super distributor, which operates as a Food Business Operator (FBO).

The company said it had not received a direct order from the Maharashtra FDA. It was informed about the matter by the distributor and subsequently obtained a copy of the communication for examination.

Patanjali Foods also clarified that the regulatory action was directed at specific stock held by the distributor rather than being a direct order against the company.

The distinction is important because the distributor and the manufacturer are separate entities in the supply chain, even though the products involved carry the Patanjali brand.

The company said it was seeking additional details and supporting documents from the distributor and regulatory authorities to understand the action.

No Authenticated Laboratory Report Confirms Quality Failure

The central point in Patanjali Foods’ response concerns the status of laboratory testing.

According to the company, FDA officials collected samples from the concerned batches of Patanjali Cow Ghee for laboratory examination.

However, as of November 3, neither Patanjali Foods nor the concerned distributor had received an authenticated laboratory report establishing that the samples failed the prescribed quality parameters.

The company argued that collecting samples for testing does not automatically establish adulteration, substandard quality or a violation of food safety standards.

Patanjali Foods said any conclusion about the product’s quality should be based on authenticated laboratory findings and established regulatory procedures.

It also stated that it would examine the findings and take appropriate corrective action if an authenticated report eventually establishes a deviation from applicable standards.

The laboratory results therefore remain central to determining whether the identified batches meet food safety requirements.

Maharashtra FDA Seizes Food Worth More Than ₹9 Crore

The action against the Patanjali distributor was part of a wider enforcement campaign by Maharashtra’s food safety authorities.

During the special festive-season drive, the FDA seized food products worth more than ₹9 crore across different locations.

The department also suspended the licences of 19 food business operators over hygiene-related violations.

The enforcement activity covered multiple categories of food products, including edible oils, rice, pulses and other items.

The action reflects increased regulatory attention towards food quality, hygiene and compliance during periods of higher consumer demand.

For food manufacturers and distributors, such enforcement drives highlight the importance of maintaining quality controls throughout the supply chain, including storage, transportation and retail distribution.

Patanjali Promises Cooperation With Authorities

Patanjali Foods said it was taking cognisance of the matter and would cooperate with the Maharashtra FDA.

The company has offered to facilitate independent verification of the identified batches if required by the authorities.

It also reiterated its commitment to product quality, consumer safety and regulatory compliance.

The company stated that it would make additional disclosures to stock exchanges if it received material updates or further directions from the regulator.

The response indicates that Patanjali Foods is waiting for the laboratory findings before reaching any conclusion about the affected stock.

For consumers, the distinction between a regulatory seizure and a confirmed laboratory failure is significant. The former indicates that authorities have taken precautionary or enforcement action, while the latter provides scientific evidence about whether a product meets the required standards.

The Bigger Picture

The development highlights the importance of food safety oversight in India’s large packaged-food market. Products such as ghee, edible oils and dairy-based foods require strict quality controls because consumers depend on manufacturers and distributors to maintain product standards throughout the supply chain.

The incident also demonstrates why regulatory sampling, laboratory testing and public disclosures must be clearly distinguished. A product being seized for investigation does not automatically establish that it is adulterated, but it does indicate that authorities have identified a matter requiring examination.

For companies operating national food brands, maintaining quality across distributors and retail networks is particularly important. Even when regulatory action concerns stock held by an independent distributor, the brand can face reputational consequences.

Looking Ahead

The next important development will be the authenticated laboratory report concerning the identified batches of Patanjali Cow Ghee. Its findings will determine whether the products meet the prescribed quality standards and whether further regulatory action is necessary. Patanjali Foods has said it will cooperate with authorities and take corrective measures if any violation is established.

For now, the company maintains that no confirmed laboratory finding has established a quality failure. The Maharashtra FDA’s action remains focused on the identified distributor stock, and the final outcome will depend on the testing process and subsequent regulatory decisions. The case will also draw attention to quality assurance and distributor-level monitoring across India’s packaged-food industry.